Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACAMUS
DRKS00004368Phase 4Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of glatiramer acetate in multiple sclerosis (MS) and clinically isolated syndrome (CIS) (2 arms), sponsored by Philipps-Universität Marburg. Started Jan 2013; status: terminated.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on DRKS00004368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004368.